WuXi Biologics has announced a strategic cooperation agreement with the Qatar Free Zone Authority (QFZ) to extend its global service network and specialized capabilities into the Middle East.

The partnership lays the groundwork for WuXi Biologics to establish its first integrated Contract Research, Development, and Manufacturing Organization (CRDMO) center in the region, located within the Qatar Free Zone. The move marks a significant step in the company’s efforts to expand its international footprint and provide end-to-end biologics solutions to customers across the Middle East.